ArticleFrontiers in public health2025
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Determinants of pneumococcal carriage by age in Africa (2000-2021): a systematic analysis.Frontiers in medicine · 2025Pooled it
- Community-acquired Pneumonia in Bangladeshi Children Under Five: Pathogen Prevalence, Resistance Trends, and Diagnostic Biomarkers.The Pediatric infectious disease journal · 2026Article
- Post-Vaccination Surveillance of Invasive Pneumococcal Disease in Ghana.Diseases (Basel, Switzerland) · 2026Article
- Measuring vaccine effects on antibiotic use and antimicrobial resistance in low and middle-income countries: A scoping review of methodological approaches, data sources, metrics, and limitations.PLOS global public health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Infections due to Methods: Nasopharyngeal samples (NP) were obtained from 420 child/adult pairs between September 2018 and October 2019. Detection, serotyping, pneumococcal isolation and antibiotic susceptibility testing were performed using standardized protocols. Additionally, vaccine impact on serotype prevalence was assessed by comparison with a group of 100 healthy carriers under 5 years of age, recruited at the same hospital between 2010 and 2014, prior to vaccine introduction. Results: We observed higher pneumococcal carriage in children (39%) than in adults (20%) and limited intrafamilial transmission. Vaccine serotypes continue to circulate among children despite vaccination, accompanied by a rise in non-vaccine serotypes. Almost 11% of fully vaccinated children still carried vaccine serotypes. Antibiotic resistance to beta-lactams and macrolides has increased; nearly one-third of the isolates were multidrug resistant while multi-drug resistant pediatric isolates were predominantly associated with serotypes 19F and 19A. Conclusion: Our findings reveal worrying trends in the epidemiology of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.